Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy

OBJECTIVE: There is evidence showing that Gleason grading of prostatic adenocarcinoma is one of the most powerful predictors of biological behavior and one of the most influential factors used to determine treatment for prostate cancer. The aim of the current study was to compare the Gleason score f...

Full description

Bibliographic Details
Main Authors: Marbele S. Guimaraes, Maisa M. Quintal, Luciana R. Meirelles, Luis A. Magna, Ubirajara Ferreira, Athanase Billis
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2008-02-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000100005
_version_ 1819176774960939008
author Marbele S. Guimaraes
Maisa M. Quintal
Luciana R. Meirelles
Luis A. Magna
Ubirajara Ferreira
Athanase Billis
author_facet Marbele S. Guimaraes
Maisa M. Quintal
Luciana R. Meirelles
Luis A. Magna
Ubirajara Ferreira
Athanase Billis
author_sort Marbele S. Guimaraes
collection DOAJ
description OBJECTIVE: There is evidence showing that Gleason grading of prostatic adenocarcinoma is one of the most powerful predictors of biological behavior and one of the most influential factors used to determine treatment for prostate cancer. The aim of the current study was to compare the Gleason score for needle biopsy to the Gleason score for the correspondent surgical specimen, find any possible difference in the biochemical (PSA) progression following surgery in upgraded cases, correlate Gleason score in the specimens to several clinicopathologic variables, and compare outcomes between patients with low-grade vs. high-grade Gleason and Gleason scores 3+4 vs. 4+3. MATERIALS AND METHODS: The study population consisted of 200 consecutive patients submitted to radical prostatectomy. Biochemical progression was defined as PSA > 0.2 ng/mL. Time to PSA progression was studied using the Kaplan-Meier product-limit analysis. RESULTS: In 47.1% of the cases, there was an exact correlation and 40.6% of cases were underestimated in the biopsies. Half of the tumors graded Gleason 6 at biopsy were Gleason score 7 at surgery. These upgraded tumors had outcomes similar to tumors with Gleason score 7 in both biopsy and surgery. There was a positive correlation of high-grade Gleason score in the surgical specimens to higher preoperative PSA, more extensive tumors, positive margins and more advanced pathologic staging. Tumors with a Gleason score > 7 have lower PSA progression-free survival vs. Gleason scores < 7. In this series, there was no significant difference when comparing Gleason scores of 3+4 vs. 4+3. CONCLUSIONS: The findings support the importance of Gleason grading for nomograms, which are used by clinicians to counsel individual patients and help them make important decisions regarding their disease.
first_indexed 2024-12-22T21:16:07Z
format Article
id doaj.art-4d8cb059f4bc48b99505dd0390ba217f
institution Directory Open Access Journal
issn 1677-5538
1677-6119
language English
last_indexed 2024-12-22T21:16:07Z
publishDate 2008-02-01
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-4d8cb059f4bc48b99505dd0390ba217f2022-12-21T18:12:22ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192008-02-01341232910.1590/S1677-55382008000100005Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomyMarbele S. GuimaraesMaisa M. QuintalLuciana R. MeirellesLuis A. MagnaUbirajara FerreiraAthanase BillisOBJECTIVE: There is evidence showing that Gleason grading of prostatic adenocarcinoma is one of the most powerful predictors of biological behavior and one of the most influential factors used to determine treatment for prostate cancer. The aim of the current study was to compare the Gleason score for needle biopsy to the Gleason score for the correspondent surgical specimen, find any possible difference in the biochemical (PSA) progression following surgery in upgraded cases, correlate Gleason score in the specimens to several clinicopathologic variables, and compare outcomes between patients with low-grade vs. high-grade Gleason and Gleason scores 3+4 vs. 4+3. MATERIALS AND METHODS: The study population consisted of 200 consecutive patients submitted to radical prostatectomy. Biochemical progression was defined as PSA > 0.2 ng/mL. Time to PSA progression was studied using the Kaplan-Meier product-limit analysis. RESULTS: In 47.1% of the cases, there was an exact correlation and 40.6% of cases were underestimated in the biopsies. Half of the tumors graded Gleason 6 at biopsy were Gleason score 7 at surgery. These upgraded tumors had outcomes similar to tumors with Gleason score 7 in both biopsy and surgery. There was a positive correlation of high-grade Gleason score in the surgical specimens to higher preoperative PSA, more extensive tumors, positive margins and more advanced pathologic staging. Tumors with a Gleason score > 7 have lower PSA progression-free survival vs. Gleason scores < 7. In this series, there was no significant difference when comparing Gleason scores of 3+4 vs. 4+3. CONCLUSIONS: The findings support the importance of Gleason grading for nomograms, which are used by clinicians to counsel individual patients and help them make important decisions regarding their disease.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000100005prostatic neoplasmsprostatectomyGleason grading system
spellingShingle Marbele S. Guimaraes
Maisa M. Quintal
Luciana R. Meirelles
Luis A. Magna
Ubirajara Ferreira
Athanase Billis
Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
International Brazilian Journal of Urology
prostatic neoplasms
prostatectomy
Gleason grading system
title Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
title_full Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
title_fullStr Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
title_full_unstemmed Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
title_short Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
title_sort gleason score as predictor of clinicopathologic findings and biochemical psa progression following radical prostatectomy
topic prostatic neoplasms
prostatectomy
Gleason grading system
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000100005
work_keys_str_mv AT marbelesguimaraes gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy
AT maisamquintal gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy
AT lucianarmeirelles gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy
AT luisamagna gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy
AT ubirajaraferreira gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy
AT athanasebillis gleasonscoreaspredictorofclinicopathologicfindingsandbiochemicalpsaprogressionfollowingradicalprostatectomy